Skip to main content
. 2019 May;16(2):361–389. doi: 10.20892/j.issn.2095-3941.2018.0290

S2.

Non-significant association in meta-analysis

PMID Gene
(variant)
Cancer type Year Comparison Ethnicity OR
(95% CI)
Publication bias/
heterogeneity
I2(%) No.
of studies
Cases/
control
Maf
25154002 ACE1
(rs4646994)
GC 2015 DD+DI vs II Diverse 1.06
(0.92–1.21)
0.791/0.317 15.1 6 4262
(1311/2951)
0.3746
27623072 CCND1
(rs603965)
GC 2016 A vs G Diverse 1.07
(0.88–1.30)
>0.05/<0.0001 77 9 3986
(1813/2173)
0.512
24978812 CD14
(rs2569190)
GC 2014 Dominant Diverse 0.99
(0.77–1.26)
0.144/0.005 63 12 5304
(2968/2336)
0.4991
23681795 CD95L
(rs763110)
GC 2013 Dominant Diverse 1.02
(0.83–1.25)
No/Na Na 8 4563
(Na/Na)
0.4696a
23681795 CD95
(rs1800682)
GC 2013 Dominant Diverse 1.00
(0.87–1.15)
Na/Na Na 8 3970
(Na/Na)
0.4543a
21570316 CDH1
(-616 G>C)
GC 2011 Recessive Diverse 1.27
(0.86–1.88)
Na/Na Na 3 1962
(565/1397)
0.2466
25599647 CDH1
(rs16260)
GC 2015 AA vs CC Diverse 1.19
(0.89–1.58)
0.323/0.001 55 22 9679
(4218/9679)
0.2545
21570316 CDH1
(+54 T>C)
GC 2011 Recessive Diverse 1.00
(0.75–1.34)
Na/Na Na 5 2280
(996/1284)
0.2667
23775011 COX-2
(-587 G>A)
GC 2013 A vs G Diverse 0.56
(0.19–1.70)
Na/<0.01 Na 3 3585
(885/2700)
0.0313
24443269 CYP1A1
(rs4646903)
GC 2014 Dominant Diverse 0.950
(0.800–1.128)
0.017/0.163 30.7 10 3460
(923/2537)
0.2237
24443269 CYP1A1
(rs1048943)
GC 2014 Dominant Diverse 0.936
(0.786–1.114)
0.113/0.876 0 8 4773
(1754/3019)
0.1577
27284439 CYP2E1
(RsaI/PstI)
GC 2016 C2 vs C1 Diverse 1.02
(0.86–1.19)
No/<0.0001 61.4 26 9237
(3727/5510)
0.1529
27284439 CYP2E1
(DraI)
GC 2016 C vs D Diverse 1.05
(0.91–1.20)
No/0.784 0 6 2595
(1225/1370)
0.1861
29332452 DNMT3B
(rs2424913)
GC 2017 T vs C Asian 1.25
(0.89–1.76)
Na/0.81 0 5 3040
(1320/1720)
0.9706
28473984 DNMT1
(rs2228611)
GC 2017 Dominant Asian 1.02
(0.83–1.26)
0.505/0.618 0 3 1469
(652/817)
0.7173
Continued